Boston's spinal cord stimulation leads approved by FDA
This article was originally published in Clinica
Executive Summary
The US FDA has granted premarket approval (PMA) for two of Boston Scientific's spinal cord stimulation leads, the Linear 3-4 and Linear 3-6. The leads are intended for use with the firm's Precision Plus spinal cord stimulator system, for the treatment of chronic pain of the trunk and/or limbs. The leads deliver electrical pulses from an implantable generator to the spinal cord – these are thought to mask pain signals to the brain. Natick, Massachusetts-based Boston plans to launch the devices in the US immediately; they are already available in Europe. The company claims it now has the "broadest range of percutaneous lead configurations in the industry".